Using drug claims data to assess the relationship of medication adherence with hospitalization and costs

Psychiatric Services

Volumn 52, Issue 6, 2001, Pages 805-811

  Svarstad, B L ^a   Shireman, T I ^a   Sweeney, J K ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; NEUROLEPTIC AGENT;

ARTICLE; DEMOGRAPHY; DRUG USE; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MEDICAID; MENTAL DISEASE; MENTAL HEALTH SERVICE; PATIENT COMPLIANCE; RISK FACTOR; SCHIZOIDISM; SCHIZOPHRENIA;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICAID; MENTAL DISORDERS; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PSYCHOTROPIC DRUGS; REGRESSION ANALYSIS; SCHIZOPHRENIA; UNITED STATES; WISCONSIN;

EID: 0034971802     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.52.6.805     Document Type: Article

References (28)

1. An economic evaluation of manic-depressive illness, 1991
2. An economic evaluation of schizophrenia, 1991
3. Managed mental health care and patterns of inpatient utilization for treatment of affective disorders
4. Health care reform for Americans with severe mental illnesses: Report of the National Advisory Mental Health Council
5. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders
6. Cost of relapse in schizophrenia
7. Frequent rehospitalization and noncompliance with treatment
8. Rehospitalization in chronic schizophrenia
9. Identifying modifiable risk factors for rehospitalization: A case-control study of seriously mentally ill persons in Mississippi
10. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients
11. Lithium use and discontinuation in a health maintenance organization
12. Compliance with medication regimens for mental and physical disorders
13. Managing the care of schizophrenia: Lessons from a 4-year Massachusetts Medicaid study
14. Use of automated databases for pharmacoepidemiology research
15. A general method of compliance assessment using centralized pharmacy records
16. Use of Medicaid data for pharmacoepidemiology
17. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia
18. The cost of antidepressant drug therapy failure: A study of antidepressant use patterns in a Medicaid population
19. Determinants of medication compliance in schizophrenia: Empirical and clinical findings
20. Psychiatric and social reasons for frequent rehospitalization
21. Neuroleptic noncompliance in schizophrenia
22. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients
23. Mental health expenditures for services for people with severe mental illnesses
24. Validity of claims for long-acting injectable medications
25. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance
26. Medication compliance and health education among outpatients with chronic mental disorders